Sara Mangsbo

Sara Mangsbo is Associate senior lecturer and Associate professor at Uppsala University and Chief Development Officer at Ultimovacs ASA/AB. Associate professor Mangsbo have a track record in drug development within immuno-oncology with a focus on antibody and peptide-based immunotherapies. In addition she has co-founded Immuneed AB, a company that provides a unique human whole blood assay for drug efficacy and toxicity assessment in preclinical testing and Vivologica AB that provides an efficient data management platform for preclinical research.